Shanxi Provincial Cancer Hospital ( Site 2227) — Taiyuan, Shanxi

Public research footprint of Shanxi Provincial Cancer Hospital ( Site 2227), compiled from the ClinicalTrials.gov public registry.

101

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Advanced Solid Tumor · Unresectable or Metastatic Gastric or Gastroesophageal Junction… · Unresectable or Metastatic Microsatellite Stable/Mismatch Repair…

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT07554339 — A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… (Recruiting)
NCT04892173 — JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Shanxi Provincial Cancer Hospital ( Site 2227)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.